by Peter | Dec 14, 2021 | VISION
FSD Pharma Unveils Videos Demonstrating Positive Effects of Lucid-MS in Treating Multiple Sclerosis in Pre-Clinical (Mouse Models) Based on more than a decade of research, Lucid-MS is a patented neuroprotective new chemical entity (“NCE”) that affects protein...
by Peter | Nov 14, 2021 | MS Medications, VISION
Overview Establishing and following a treatment plan with your healthcare provider is the best strategy for managing your MS. Medications are used in multiple sclerosis (MS) to modify the disease course, treat relapses — also called attacks...
by Peter | Nov 14, 2021 | Research, VISION
Solutions for People with MS November 9, 2021MS healthcare providers and researchers participated in the 35th Annual Meeting of the Consortium of MS Centers (CMSC) in Orlando, Florida, to share findings and learn the latest about diagnosing and treating MS, and to...
by Peter | Nov 14, 2021 | Fatigue, VIABILITY
The majority of people living with multiple sclerosis (MS) — a chronic autoimmune disease affecting the central nervous system — say that fatigue is their most prominent symptom, according to the National Multiple Sclerosis Society (NMSS). Research...
by Peter | Nov 14, 2021 | Uncategorized
Good nutrition is tied to good health, as well as to the prevention and treatment of many conditions. Getting the recommended amounts of vitamins each day is an important part of the nutrition equation, and B vitamins are essential for preventive care. Abundant in...
by Peter | Nov 10, 2021 | Research, VIABILITY, VISION
MNT’s Sunday Supplement: Genetic evidence links vitamin D deficiency to mortality risk in someVitamin D is a topic Medical News Today keeps coming back to. We have covered research into the link between vitamin D and the microbiome, the mixed evidence for the health...
